植入型心脏电子装置无症状囊袋感染的危险因素、预后与炎症因子预测价值的分析
Analysis of Risk Factors and the Predictive Value of Inflammatory Factors of Cardiac Implantable Electronic Device Relevant Asymptomatic Pockets Infections
DOI: 10.12677/ACM.2021.112115, PDF,    科研立项经费支持
作者: 崔 文:中国医学科学院北京协和医学院国家心血管病中心阜外医院心内科,北京;刘俊鹏, 高 旭, 王志蕾, 金 鑫, 吴素娟, 佟佳宾, 杨杰孚, 邹 彤*:卫生部北京医院心内科电生理室,北京;林高峰:北京协和医学院研究生院,北京
关键词: 植入型心脏电子装置亚临床感染危险因素预后炎症因子Cardiac Implantable Electronic Device Subclinical Infections Risk Factor Prognosis Inflammatory Factor
摘要: 目的:将心脏植入电子装置(cardiac implantable electronic device, CIED)囊袋微生物培养阳性但却不合并任何临床感染症状(囊袋周围皮肤出现红肿热痛、破溃、化脓等症状可以确诊囊袋感染或CIED相关的感染性心内膜炎)的情况定义为无症状囊袋感染,即亚临床囊袋感染。本研究旨在探索无症状囊袋感染的危险因素、预后以及炎症因子水平与无症状CIED囊袋感染之间的关系,寻求早期识别亚临床囊袋感染的方法。方法:连续入选2011年1月至2014年10月在卫生部北京医院及阜外医院行CIED的患者一共179例(排除临床确诊囊袋感染或植入性心脏电子装置相关感染性心内膜炎患者),留取血培养和囊袋组织培养,收集相关临床资料,相关结果进行单因素及多因素回归分析。并对病人进行为期60个月的随访。在上述病人中随机抽取108例行5种炎性因子(CRP、IL-1、IL-6、MCP、PCT)测定,分析其中囊袋培养阴性组与囊袋培养阳性组的炎症因子的差异。抽取40例正常人的炎症因子与上述患者进行比较。结果:179例行心脏植入电子装置更换的患者,血培养均为阴性,所有入选患者中,囊袋组织培养结果阳性25例(14.0%)。检出率最高的致病菌为凝固酶阴性葡萄球菌,共19例(76.0%)。多因素Logistic回归分析发现男性(P = 0.001, OR = 14.001, 95%CI: 2.825~69.401),术前三月内抗生素使用大于10天(P = 0.002, OR = 27.935, 95%CI: 3.446~226.437),服用抗血小板药物(P = 0.008, OR = 3.761, 95%CI: 1.406~10.058)为无症状亚临床囊袋感染的独立危险因素。囊袋培养阳性组随访期内有4%的患者(1人/25人)因囊袋感染返院清创,阴性组无人报告临床囊袋感染。CIED更换患者的炎性因子的数值(CRP、IL-1、IL-6、MCP、PCT)明显高于正常人对照组(P = 0.001),囊袋培养阳性的患者与囊袋培养阴性的患者的炎性因子之间不存在显著差异。剔除基础疾病后的亚组分析中,CIED更换患者的炎症因子仍明显高于正常对照组,囊袋培养阳性与囊袋培养阴性的患者之间炎性因子仍未见显著差异。结论:临床上无感染表现的CIED植入患者中,无症状囊袋感染发生率约14.0%,其独立的危险因素是男性,长期服用抗血小板药物与术前3月内使用抗生素大于10天。无症状囊袋感染的患者迟发临床囊袋感染的几率为4%。CIED更换者的炎性因子整体水平明显升高,提示患者可能处于炎症反应激活的状态,但利用炎性因子检测协助诊断CIED亚临床感染目前证据尚不充分。
Abstract: Objective: To investigate the risk factors, prognosis and the predictive value of 5 different inflammatory factors in CIED associated subclinical generator pocket infections (asymptomatic infection also called subclinical. Methods: A total of 179 patients undergoing replacement of CIED (cardiac implanted electronic devices) in Beijing hospital and Fuwai Hospital between January 2011 and October 2014 were recruited. Microbiological cultures of blood and generator pockets were consecutively obtained. Patients with clinical evidence of CIED infection were excluded. Patients were regularly followed up 60 months after discharge. Univariate and multivariable analyses were performed to identify significant risk factors for positive generator pockets culture patients. Five different inflammatory factors (CRP, IL-1, IL-6, MCP, PCT) were measured in 108 patients randomly selected from patients above, and the differences of inflammatory factors were analyzed between patients with positive pocket tissue cultures and patients with negative pocket tissue cultures. The inflammatory factors of 40 normal people were compared with the patients above too. Results: All blood cultures of the 179 patients were negative. Positive cultures from the generator pocket were found in 25 patients (14.0%). The most common bacteria isolated were coagulase negative staphylococci (76.0%). A multivariable logistic regression identified that male sex (P = 0.001, OR = 14.001, 95%CI: 2.825~69.401), antibiotic use 3 months before implantation (P = 0.002, OR = 27.935, 95%CI: 3.446~226.437), antiplatelet therapy (P = 0.008, OR = 3.761, 95%CI: 1.406~10.058) as independent risk factors for asymptomatic bacterial colonization of generator pockets. 4% patients with positive pocket culture showed clinical sign of infection during 60 months follow-up, while none of patients with negative pocket culture reported any sign of CIED relevant infections. Significant difference in inflammatory factors (including CRP, IL-1, IL-6, MCP, PCT) had been identified between patients who replaced CIED and the normal control group, however there was no relevance between inflammatory factors and generator pocket cultures even when all the fundamental clinical complications were excluded. Conclusion: 14.0% of patients undergoing CIED replacement have an asymptomatic bacterial colonization of generator pockets. Independent factors for positive pockets culture is male sex, antibiotic use 3 months before implantation, antiplatelet therapy 0.4% of patients with positive pocket culture develop clinical CIED infection. Inflammatory factors are significantly elevated in patients undergoing CIED replacement suggesting a strong inflammatory reaction in those patients, however, there is not sufficient evidence indicating predictive value of inflammatory factors in early diagnosis of subclinical CIED infections.
文章引用:崔文, 刘俊鹏, 高旭, 王志蕾, 金鑫, 吴素娟, 林高峰, 佟佳宾, 杨杰孚, 邹彤. 植入型心脏电子装置无症状囊袋感染的危险因素、预后与炎症因子预测价值的分析[J]. 临床医学进展, 2021, 11(2): 810-820. https://doi.org/10.12677/ACM.2021.112115

参考文献

[1] Cabell, C.H., Heidenreich, P.A., Chu, V.H., Moore, C.M., Stryjewski, M.E., Corey, G.R. and Fowler, V.G. (2004) Increasing Rates of Cardiac Device Infections among Medicare Beneficiaries: 1990-1999. American Heart Journal, 147, 582-586. [Google Scholar] [CrossRef] [PubMed]
[2] Voigt, A., Shalaby, A., Saba, S., et al. (2006) Rising Rates of Cardiac Rhythm Management Device Infections in the United States: 1996 through 2003. Journal of the American College of Cardiology, 48, 590-591. [Google Scholar] [CrossRef] [PubMed]
[3] Baddour, L.M., Bettmann, M.A., Bolger, A.F., et al. (2003) Nonvalvular Cardiovascular Device-Related Infections. Circulation, 108, 2015-2031. [Google Scholar] [CrossRef
[4] Tarakji, K.G., Chan, E.J., Cantillon, D.J., Doonan, A.L., Hu, T., Schmitt, S., Fraser, T.G., Kim, A., Gordon, S.M. and Wilkoff, B.L. (2010) Cardiac Implantable Electronic Device Infections: Presentation, Management, and Patient Outcomes. Heart Rhythm, 7, 1043-1047. [Google Scholar] [CrossRef] [PubMed]
[5] Chua, J.D., Abdul-Karim, A., Mawhorter, S., Procop, G.W., Tchou, P., Niebauer, M., Saliba, W., Schweikert, R. and Wilkoff, B.L. (2005) The Role of Swab and Tissue Culture in the Diagnosis of Implantable Cardiac Device Infection. Pacing and Clinical Electrophysiology, 28, 1276-1281. [Google Scholar] [CrossRef] [PubMed]
[6] Kleemann, T., Becker, T., Strauss, M., et al. (2010) Prevalence of Bacterial Colonization of Generator Pockets in Implantable Cardioverter Defibrillator Patients without Signs of Infection Undergoing Generator Replacement or Lead Revision. Europace, 12, 58-63. [Google Scholar] [CrossRef] [PubMed]
[7] 刘俊鹏, 杨杰孚, 佟佳宾, 等. 心血管植入型电子器械更换患者无症状囊袋感染相关危险因素研究[J]. 中华心律失常学杂志, 2013(6): 422-426.
[8] Baddour, L.M., Epstein, A.E., Erickson, C.C., et al. (2010) Update on Cardiovascular Implantable Electronic Device Infections and Their Management: A Scientific Statement from the American Heart Association. Circulation, 121, 458-477. [Google Scholar] [CrossRef
[9] Johansen, J.B., Jorgensen, O.D., Moller, M. and Arnsbo, P. (2011) Infection after Pacemaker Implantation: Infection Rates and Risk Factors Associated with Infection in a Population-Based Cohort Study of 46299. European Heart Journal, 32, 991-998. [Google Scholar] [CrossRef] [PubMed]
[10] Lekkerkerker, J.C., van Nieuwkoop, C., Trines, S.A., van der Bom, J.G., Bernards, A., van de Velde, E.T., Bootsma, M., Zeppenfeld, K., Jukema, J.W., Borleffs, J.W., Schalij, M.J. and van Erven, L. (2009) Risk Factors and Time Delay Associated with Cardiac Device Infections: Leiden Device Registry. Heart, 95, 715-720. [Google Scholar] [CrossRef] [PubMed]
[11] Habid, A., Muna, I., Baddour, L.M., et al. (2013) Impact of Prior Aspirin Therapy on Clinical Manifestations of Cardiovascular Implantable Electronic Device Infections. Europace, 15, 227-235. [Google Scholar] [CrossRef] [PubMed]
[12] Pichlmaier, M., Marwitz, V., Kuhn, C., et al. (2008) High Prevalence of Asymptomatic Bacterial Colonization of Rhythm Management Devices. Europace, 10, 1067-1072. [Google Scholar] [CrossRef] [PubMed]
[13] Pepys, M.B., Hirschfield, G.M., Pepys, M.B. and Hirschfield, G.M. (2003) C-Reactive Protein: A Critical Update. Journal of Clinical Investigation, 111, 1805-1812. [Google Scholar] [CrossRef
[14] Assicot, M., Bohuon, C., Gendrel, D., Raymond, J., Carsin, H. and Guilbaud, J. (1993) High Serum Procalcitonin Concentrations in Patients with Sepsis and Infection. The Lancet, 341, 515-518. [Google Scholar] [CrossRef
[15] Xing, Z., Gauldie, J., Cox, G., Baumann, H., Jordana, M., Lei, X.F. and Achong, M.K. (1998) IL-6 Is an Antiinflammatory Cytokine Required for Controlling Local or Systemic Acute Inflammatory Responses. The Journal of Clinical Investigation, 101, 311-320. [Google Scholar] [CrossRef
[16] Schuetz, P., Mueller, B. and Trampuz, A. (2007) Serum Procalcitonin for Discrimination of Blood Contamination from Bloodstream Infection Due to Coagulase-Negative Staphylococci. Infection, 35, 352-355. [Google Scholar] [CrossRef] [PubMed]
[17] Becker, K.L., Snider, R. and Nylen, E.S. (2008) Procalcitonin Assay in Systemic Inflammation, Infection, and Sepsis: Clinical Utility and Limitations. Critical Care Medicine, 36, 941-952. [Google Scholar] [CrossRef
[18] Zou, T., Zhang, Z.G., Zou, C.G., et al. (2014) Subclinical Infections of Cardiac Implantable Electronic Devices: Insights into the Host-Bacteria Dialog from Blood and Pocket Tissue with Pyrosequencing. International Journal of Cardiology, 174, 545-549. [Google Scholar] [CrossRef] [PubMed]
[19] Schultzle, H., Forster, J. and Superti-Furga, A. (2009) Is Serum Procalcitonin a Reliable Diagnostic Marker in Children with Acute Respiratory Tract Infections. European Journal of Pediatrics, 168, 117-1124. [Google Scholar] [CrossRef] [PubMed]
[20] Ingram, P.R., Inglis, T. and Moxon, D. (2010) Procalcitonin and C-Reactive Protein in Severe H1N1 Influenza Infection. Intensive Care Medicine, 36, 528-532. [Google Scholar] [CrossRef] [PubMed]
[21] Carsin, H., Assicot, M., Feger, F., et al. (1997) Evolution and Significance of Circulating Procalcitonin Levels Compared with Il-6, TNF-α, and Endotoxin Levels Early after Thermal Injury. Burns, 23, 218-224. [Google Scholar] [CrossRef
[22] Riedel, S. (2012) Procalcitonin and the Role of Biomarkers in the Diagnosis and Management of Sepsis. Diagnostic Microbiology & Infectious Disease, 73, 221-227. [Google Scholar] [CrossRef] [PubMed]